CV (until May 2008)

CV: Davood Beiki
[English]
7. Matloobi M., Rafii H., Beiki D., Khalaj A., Kamali-Dehghan M.,“ Synthesis
of radioiodinated labeled peptides”, Journal of Radioanalytical and
Nuclear Chemistry 2003; 257(1): 71-73. [English]
8. Beiki D., Shahhosseini S., Eftekhari M., Takavar A. “Contamination
monitoring of Na 131I level in therapy unit of Research Institute for Nuclear
Medicine, Tehran University of Medical Sciences, by indirect method (wipe
test)”, Iranian Journal of Nuclear Medicine, 2003; 19: 9-16. [Persian]
9. Beiki D., Amini M., Dowlatabadi R., Pirali M. “Comparative bioavailability of
two tablet formulation of dipyridamole in healthy male volunteers”,
Iranian Journal of Pharmaceutical Research, 2003; 2: 213-216.
[English]
10. 10. Fard-Esfahani A., Olamaei R., Eftekhari M., Saghari M. and Beiki D.
“Radioiodine therapy effects on salivaroy gland function in patients with
differentiated thyroid cancer”, Iranian Journal of Nuclear Medicine,
2003; 19: 17-22. [Persian]
11. 11. Shahosseini S., Beiki D., Eftekhari M. “Gamma-scintigraphy in the
evaluation of drug delivery systems", Iranian Journal of Nuclear
Medicine, 2003; 20: 26-38. [Persian]
12. 12. Eftekhari M., Olamaei R., Fard A., Beiki D., Saghari M. “ 131I-MIBG scintigraphy in carcinoid tumor with liver metastases”, Iranian Journal of
Nuclear Medicine, 2003; 20:7-12. [Persian]
13. Eftekhari M., Takavar A.,Ansari-Gilani K., Akhzari F., Fard A., Beiki D., “
Effects of treatment with radioiodine ( 131I) on the gonadal function of the
hyperthyroid patients”, Iranian Journal of Nuclear Medicine, 2003; 20:
7-12. [English]
14. Takavar A., Eftekhari M., Beiki D., Saghari M., Mostaghim M., Sohrabi M. “
Qualitative evaluation of Chang method of attenuation correction on heart
SPECT by using custom made heart phantom”, Iranian Journal of
Nuclear Medicine, 2003; 20: 13-17. [English]
15. Beiki D., Shahhosseini S., Dadashzadeh S., Eftekhari M., Tayebi H.,
Moosazadeh-Rashti G. “ Determination of radiation dose rates and urinary
activity of patients received sodium iodide-131 for treatment of
differentiated thyroid carcinoma”, Iranian Journal of Nuclear Medicine,
2004; 21: 1-14. [Persian]
16. Saghari M., Fallahi B., Eftekhari M., Iravani M., Izadyar S., Esmaili J., Beiki
D., Fard A. “ Value of 99mTc-Mibi scintigraphy in active disease and
remission phase of multiple myeloma”, Iranian Journal of Nuclear
Medicine, 2004; 21: 15-24. [Persian]
17. Eftekhari M., Sadeghi R., Fard A., Beiki D., Fallahi B., Saghari M.,
“Reverse re-distribution in myocardial perfusion scan with 201Tl”, Iranian
Journal of Nuclear Medicine, 2004; 21: 25-32. [Persian]
18. Eftekhari M., Assadi M., Fard-Esfehani A., Beiki D., and Fallahi B.
“Dystrophic calcinosis cutis and SLE; the bone scan pattern (Case report)”,
Iranian Journal of Nuclear Medicine, 2004; 22: 1-4. [Persian]
19. Fard-Esfehani A., Eftekhari M., Aliyari N., Saghari M., Beiki D. “Effects of
treatment with radioactive iodine on gonadal functions in patients with
differentiated thyroid cancer”, Tehran University Medical Journal ,
2004; 62(1): 31-36. [Persian]
20. Fard A., Emami F., Eftekhari M., Saghari M., Fallahi B., Beiki D., and
Takavar A. “The value of myocardial perfusion imaging in differentiating
between idiopathic dilated cardiomyopathy from the ischemic form”,
Iranian Journal of Nuclear Medicine, 2004; 22: 15-20. [Persian]
21. Shahhosseini S., Beiki D., Dadashzadeh S., Eftekhari M., Tayebi H.,
Moosazadeh G. “Radiation dose rate and urinary activity in patients with
differentiated thyroid carcinoma treated with radioiodine-131; a survey in
Iranian population”, Hellenic Journal of Nuclear Medicine, 2004; 7(3):
192-194. [English]
22. Fard A., Fallahi B., Olamaei R., Eftekhari M., Beiki D., Saghari M., “Semiquantitative
assessment of salivary gland function in patients with
mhtml:file://C:\Documents and Settings\Dr\Desktop\CV Davood Beiki.mht
Page 3 of 18
2008/05/30